Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T22:53:55.576Z Has data issue: false hasContentIssue false
  • English
  • Français

HIV and the Blood Supply: Assessing MANTRA Legislation

Published online by Cambridge University Press:  17 May 2016

Carolyn R. Thompson
Carolyn R. Thompson*
Affiliation:
University of North Carolina—Charlotte, USA
Get access

Abstract

Despite a dramatic decline in transfusion-associated AIDS, increased safety of the national blood supply, and voluntary efforts to find alternatives to homologous blood sources, Americans remain fearful about the possibility of acquiring AIDS through a blood transfusion. Numerous states have initiated legislative efforts that would require explicit warnings about blood safety and that would direct patients to alternative sources of blood. These proposed laws—known as MANTRA bills, for “mandatory notification of transfusion alternatives”—would require physicians to advise patients of blood transfusion options prior to any surgery. Many would mandate the development of new informed consent documents and involve health departments in the implementation of new regulations regarding transfusions. This article concludes that MANTRA legislation is primarily a symbolic attempt to reassure the public about AIDS. It mandates practices that are being adopted voluntarily; it will not make the blood supply safer; it will increase the cost of health care to individuals and in the aggregate; it may diminish the number of donors to the voluntary blood supply system; and it is likely to intensify public fear about the risk of a blood transfusion.

Type
HIV and the Blood Supply
Information
Politics and the Life Sciences , Volume 14 , Issue 2 , August 1995 , pp. 221 - 228
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Legislation Cited

California Assembly Bill 787, Amendment to the Health and Safety Code, February 1991.Google Scholar
Georgia House Bill 1576, Amendment to Title 31 of the Official Code of Georgia, September 1992.Google Scholar
Illinois Assembly Bill 4164, Blood Safety Act, April 1992.Google Scholar
Indiana Senate Bill 451, Blood Transfusions and Donations, April 1993.Google Scholar
Maryland Senate Bill 427, Blood Safety Act, March 1993.Google Scholar
Senate Bill 64, Blood Safety Act, February 1994.Google Scholar
Massachusetts House Bill 2643, An Act Requiring Surgeons to Inform Patients of Blood Transfusion Options, May 1991.Google Scholar
Michigan House Bill 5144, Amendment to Public Health Code, September 1991.Google Scholar
New Jersey Senate Bill 3053, Blood Safety Act, June 1991.Google Scholar
New York Assembly Bill 7711, Blood Safety Act, April 1993.Google Scholar
Senate Bill 5284, Blood Safety Act, May 1993.Google Scholar
Pennsylvania House Bill 1944, Blood Safety Act, June 1993.Google Scholar

References

Berry, K.M.(1991). “A Multi Million Dollar Business in a NonProfit World.” New York Times (January 7):F8–F9.Google Scholar
Busch, M.P. et al.(1995). “Time Course of Detection of Viral and Serologic Markers Preceding Human Immunodeficiency Virus Type 1 Seroconversion: Implications for Screening of Blood and Tissue Donors.” Transfusion 35:91–97.CrossRefGoogle Scholar
“California Law Requires Informed Consent on Risk of Transfusion” (1990). Hospital Infection Control 17(3):34–36.Google Scholar
Campbell, S., ed. (1986). “AABB Issues Recommendations on Informed Consent.” AABB Newsbriefs (July):1–3.Google Scholar
Colebunders, R. et al.(1991). “Seroconversion Rate, Mortality, and Clinical Manifestations Associated with the Receipt of a Human Immunodeficiency Virus-Infected Blood Transfusion in Kinshasa, Zaire.” Journal of Infectious Diseases 164:450–56.CrossRefGoogle Scholar
Crenshaw, T.L.(1989). “Transfusions: It's a Bloody Shame.” The Humanist 43(3):16–20.Google Scholar
Donegan, E. et al.(1990). “Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody Positive Donations.” Annals of Internal Medicine 113:733–39.CrossRefGoogle Scholar
Douglas, M. and Wildavsky, A.(1982). Risk and Culture. Berkeley, CA: University of California Press.Google Scholar
Edelman, M.(1964). The Symbolic Uses of Politics. Urbana, IL: University of Illinois Press.Google Scholar
Etchason, J. et al.(1995). “The Cost Effectiveness of Preoperative Autologous Blood Donations.” New England Journal of Medicine 332:719–24.CrossRefGoogle Scholar
Goodnough, L.T. and Shuck, J.(1990). “Risks Options and Informed Consent for Blood Transfusion in Elective Surgery.” American Journal of Surgery 159:602–9.CrossRefGoogle Scholar
Herman, R.(1992). “Do It Yourself Blood Transfusions.” Washington Post (September 8):WH10-14.Google Scholar
Holland, P.V.(1991). “Informed Consent for Transfusions.” Letter to the Editor. Journal of Thoracic and Cardiovascular Surgery 102:934.CrossRefGoogle Scholar
Jacobson, L.(1993). “Fear Fuels Demand for Recycled and Synthetic Blood.” Wall Street Journal (September 15):B4.Google Scholar
Kolins, J. and Kolins, M.(1990). “Informed Consent, Risk and Blood Transfusion.” Journal of Thoracic and Cardiovascular Surgery 100:88–91.CrossRefGoogle Scholar
Leparc, G.F.(1991). “Informed Consent for Blood Transfusion.” Journal of the Florida Medical Association 78:423–25.Google Scholar
Peterman, T.A., Lui, K.J., Lawrence, D.N., and Aleen, J.R.(1987). “Estimating the Risks of Transfusion-Associated Acquired Immune Deficiency Syndrome and Human Immunodeficiency Virus Infection.” Transfusion 27:371–74.CrossRefGoogle Scholar
Petersen, L.R.(1994). Chief of HIV Seroepidemiology Branch, Division of HIV-AIDS, Centers for Disease Control and Prevention, Atlanta, GA. Personal communication, October 12.Google Scholar
Petersen, L.R., Satten, G.A., Dodd, R., Busch, M., Kleinman, S., Grindon, A., B. Lenes, and the HIV Seroconversion Study Group (1994). “Duration of Time from Onset of Human Immunodeficiency Virus Type 1 Infectiousness to Development of Detectable Antibody.” Transfusion 34:283–89.CrossRefGoogle Scholar
Petersen, L.R., Simonds, R.J., and Koistinen, J.(1993). “HIV Transmission through Blood, Tissues and Organs.” AIDS 7(1):S99–S107.CrossRefGoogle Scholar
Pindyck, J.(1988). “Editorial Review: Transfusion-Associated HIV Infection: Epidemiology, Prevention and Public Policy.” AIDS 2:239–48.CrossRefGoogle Scholar
Rosen, N.R.(1989). “Current Transfusion Issues.” Indiana Medicine 82:764–66.Google Scholar
Schoub, B.D.(1994). AIDS and HIV in Perspective. Cambridge: Cambridge University Press.Google Scholar
Selik, R.M., Ward, J.W., and Buehler, J.W.(1993). “Trends in Transfusion-Associated Acquired Immune Deficiency Syndrome in the United States, 1982 through 1991.” Transfusion 33:890–93.CrossRefGoogle Scholar
Shepherd, L.(1992). “The Risk of Transfusion-Associated AIDS: Offering Patients an Active Role in Their Care.” American Journal of Medical Quality 7(4):111–15.Google Scholar
Short, J.F.(1992). “Defining, Explaining and Managing Risk.” In Short, J.F. and Clarke, L.(eds.), Organizations, Uncertainties and Risk. Boulder, CO: Westview.Google Scholar
Slovic, P.(1987). “Perception of Risk.” Science 236:280–85.CrossRefGoogle ScholarPubMed
“Survey Shows Changes in Public Attitudes about America's Blood Supply and AIDS” (1993). AABB News, May 19.Google Scholar
Thomas, A.T. and Perry, M.C.(1989). “Autologous Blood Transfusions.” Missouri Medicine 86(3):157–61.Google Scholar
Umlas, J.(1991). Personal Correspondence to Representative Carmen D. Buell, Chairman Joint Committee on Health Care, Massachusetts House of Representatives.Google Scholar
Viele, M.V. and Donegan, E.A.(1992). “Rational Use of Blood and Blood Components.” Otolaryngologic Clinics of North America 25:1322–39.CrossRefGoogle Scholar
Voelker, R.(1995). “Anesthesia-Related Risks Have Plummeted.” Journal of the American Medical Association 273:445–46.Google Scholar
Widmann, F.K.(1990). “Informed Consent for Blood Transfusion: Brief Historical Survey and Summary of a Conference.” Transfusion 30:460–70.CrossRefGoogle Scholar